Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Press Releases
Johnson & Johnson Extends Tender Offer for Mentor Corporation
Ektron Partners Attain CMS400.NET V7.6 Certification
Zacks Bull & Bear of the Day Highlights: Isis Pharmaceuticals, LeapFrog, Johnson & Johnson, Exxon Mobil and iPass
Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.
BridgewaterEquity.Com Free Fundamental Sector &Amp; Market Research on NVS, JNJ, GM and DOW
Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.
Zacks Analyst Blog Highlights: Qualcomm, Inc., Nokia, Johnson & Johnson, Cypress Bioscience, Inc. And Forest Laboratories, Inc.
SSON: A Year in Review and Predictions for 2009
Johnson & Johnson Extends Tender Offer for Omrix Biopharmaceuticals, Inc.
Johnson & Johnson Strengthens Wellness & Prevention Platform with Acquisition of Human Performance Institute(TM)
Beacon Equity Issues Technical Trade Alerts on Drug Manufacturers: BMY, JNJ, PFE, NVS, GSK, ABT
Decorative Bugs - Genetically Engineered Bacteria That Fluoresce When Exposed to Toxic Chemicals, Spell Out HUJI (Hebrew University of Jerusalem) on a Petri Dish. (Photo: Business Wire)
Pharmaceutical and Health Care Experts to Detail Cost-Cutting Capabilities of Secure Digital Signatures
SciQuest Appoints Gamble Heffernan As Vice President of Marketing
AtTask Delivers Bundled Integration Via Boomi AtomSphere
Johnson & Johnson Begins Tender Offer to Acquire Mentor Corporation
Johnson & Johnson Announces Receipt of Israeli Antitrust Approval for Acquisition of Omrix
Global Mapping Tool Demonstrates Medical Donation Impact
TNS Media Intelligence Reports U.S. Advertising Expenditures Declined 1.7 Percent in First Nine Months of 2008
Emma and Aiden Are Top Baby Names of 2008
S&P 500 Stock Buybacks Continue at Lower Levels; Retreat 48% in Third Quarter
Eli Lilly and Company Joins SAFE-BioPharma Association
S&P 500 Stock Buybacks Continue at Lower Levels; Retreat 48% in Third Quarter
Winglatino Announces Two Key Account Management Hires
AtTask Idea Share Brings Customer-Driven Development to Project Management Software
BenchmarkJournal.Com (Complimentary) Analyst Review for AMR, USB, MU and JNJ
QuickArrow Selects Mzinga to Power User Community
UPI NewsTrack Business
Ektron Unveils Complete Services Solution at Gilbane Conference
Johnson & Johnson Announces Definitive Agreement to Acquire Mentor Corporation
Research and Markets: Independent Forecasts and Competitive Intelligence on Lebanon's Pharmaceuticals and Healthcare Industry for Q4 2008
Johnson & Johnson Begins Tender Offer to Acquire Omrix
Research and Markets: New Report Estimates That the United Arab Emirates' (UAE) Drug Market Expenditure Was AED2.71bn (US$0.74bn) In 2007
HealthMedia Announces Industry's First Individually Tailored Physical Activity Intervention and Other Innovative New Program Features
Johnson & Johnson Announces Definitive Agreement to Acquire Omrix
FDA Advisory Panel Unanimously Recommends Approval of NAVISTAR(R) THERMOCOOL(R) Catheter for Atrial Fibrillation
FDA Advisory Panel Unanimously Recommends Approval of NAVISTAR® THERMOCOOL® Catheter for Atrial Fibrillation
FDA Advisory Panel Unanimously Recommends Approval of NAVISTAR® THERMOCOOL® Catheter for Atrial Fibrillation
Beacon Equity Issues Technical Trade Alerts on Drug Manufacturers: NVS, JNJ, PFE, GSK, ABT, AZN
Key Challenges and Issues Facing the World Online Services Market Brief
Key Challenges and Issues Facing the World Online Services MarketBrief
Jury Awards $16.5 Million in Fentanyl Death Case
Jury Awards $16.5 Million in Fentanyl Death Case
BIO-Europe 2008 Exhibitor and Presenter Profiles
Best Practice Database Shares Best Practices in Biopharma Public Relations
Soft Contact Lenses Do Not Lead to 'Myopic Creep' in Children, Study Shows
Study Finds Catheter Ablation with the NAVISTAR(R) THERMOCOOL(R) Catheter Superior to Anti-Arrhythmic Drug Therapy for the Treatment of Symptomatic, Paroxysmal Atrial Fibrillation
Seven Summits Research Releases Alerts on CSCO, JNJ, APC, RF, and CI
SMARTANALYST, Inc. Managing Director of Research, Marc Rovner, to Appear As Featured Speaker at Pharmaceutical Strategy Series Annual Conference
Johnson & Johnson to Participate in Credit Suisse 2008 Health Care Conference
SMARTANALYST, Inc. Managing Director of Research, Marc Rovner, to Appear As Featured Speaker at Pharmaceutical Strategy Series Annual Conference
Ciena Selects Mzinga to Deploy Partner Community
Long-Term Results of VisionCare's Implantable Telescope for End-Stage Macular Degeneration Published in the American Journal of Ophthalmology
Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder
Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder
TCT2008 Concludes with Presentation of Positive Data for the CYPHER(R) Sirolimus-eluting Coronary Stent
ConvaTec Names Presidents of Wound Therapeutics and Ostomy Care Business Units
Zacks Analyst Blog Highlights: Cache, Inc., WPP Group Plc., Companhia Vale Do Rio Doce, Vertex Pharmaceuticals Inc. And Johnson & Johnson
Johnson & Johnson Establishes Wellness & Prevention Platform with Acquisition of HealthMedia, Inc.
Patient Enrollment Complete for Pivotal Trial of the NEVO(TM) Sirolimus-eluting Coronary Stent with Unique Reservoir Technology
Illinois Technology Association Congratulates Members, Fieldglass and Cleversafe, for Earning Coveted Chicago Innovation Awards
Drug Store News' Retail Clinician Launches Debut Retail Clinician Family Health Edition With Support From McNeil Consumer Healthcare
Vision-Related Quality of Life Benefits Improve More for Children Who Wear Contact Lenses Versus Glasses
Zacks Analyst Blog Highlights: Johnson & Johnson, CarMax, Inc., Rackable Systems, Inc., DURECT Corp. And Alpharma Inc.
Johnson & Johnson Reports 2008 Third-Quarter Results:
Cordis Announces New Leadership Positions in Key Business Groups
Seven Summits Research Releases Comments on KO, GILD, NUE, JNJ and UTX
FDA Approves New Injection Site for RISPERDAL(R) CONSTA(R) for Schizophrenia Treatment
Johnson & Johnson Announces Executive Appointments: Sheri McCoy, Worldwide Chairman, Pharmaceuticals Group, and Alex Gorsky, Worldwide Chairman, Surgical Care Group
The HealthCentral Network Names Peter A. Horn Chief Revenue Officer
Boston Scientific Announces Third Quarter Adjustments
Rosetta Named Microsoft National System Integration Partner
Johnson & Johnson to Host Analyst Meeting to Discuss Third-Quarter Financial Results and Review Pharmaceutical Business
Political Instability Is Likely To Continue To Hold Back Development In The Lebanese Healthcare System
Analyst Reports for ConocoPhillips, Ford Motor Company, Banco Bradesco S.A. And Johnson &Amp; Johnson
AtTask Announces New Customer-Focused Release of @Task Project Management Software
AtTask Announces New Customer-Focused Release of @Task Project Management Software
Yissum Announces a Novel Method for Swift and Robust Pattern Recognition
Boston Scientific Announces Court Decision
U.S. District Court in Delaware Enters Final Judgment of Approximately $1.2 Billion to Cordis Corporation on Patents Infringed by Medtronic, Inc. and Boston Scientific Corporation
Monthly Replacement Contact Lens Wearers Report a Decrease in Wearing Comfort Over the Course of a Month, Research Shows
TNS Media Intelligence Reports U.S. Advertising Expenditures Declined 1.6 Percent in First Half 2008
Social Media Visionary Shares How Business Leaders Can Unleash the Wisdom of Crowds
TNS Media Intelligence Reports U.S. Advertising Expenditures Declined 1.6 Percent in First Half 2008
Zacks Analyst Interview Highlights: Abbott Labs, Amgen, Johnson & Johnson and Boston Scientific
Zacks Analyst Interview Highlights: Abbott Labs, Amgen, Johnson & Johnson and Boston Scientific
Zacks Analyst Blog Highlights: Johnson & Johnson, Inc., Boston Properties, Inc., Matsushita Electric Industrial Co., Ltd., Deckers Outdoor Corp. And Mechel Steel Group.
Seven Summits Research Releases Alerts on GS, JNJ, YHOO, LVS, and AA
Zacks Analyst Blog Highlights: Johnson & Johnson, Inc., Boston Properties, Inc., Matsushita Electric Industrial Co., Ltd., Deckers Outdoor Corp. And Mechel Steel Group.
Following Complaint by Johnson & Johnson Vision Care, Inc., Court Orders Ocular Insight, Inc. to Discontinue Certain Advertising/Promotional Claims to Eye Care Professionals About Its Clear 58 Contact Lenses
U.S. District Court in Delaware Reinstates Damage Awards to Cordis Corporation on Patents Infringed by Medtronic, Inc. and Boston Scientific Corporation
Christine A. Poon Plans Retirement from Johnson & Johnson in Early 2009
Analyst Reports for Tesoro Corporation, CSX Corporation, Johnson &Amp; Johnson and Procter &Amp; Gamble Company
Clinical Data Indicate that Percutaneous Coronary Intervention with the CYPHER(R) Sirolimus-eluting Coronary Stent Is Comparable to Bypass Surgery in Key Safety Measures in Patients with Diabetes and Multi-Vessel Disease
VISTAKON(R) Brings ACUMINDER(TM) to Facebook Users
First Patient Enrolled in Study Evaluating S.M.A.R.T. (R) Nitinol Self-Expandable Stent System in Leg Disease
2008 Summer Olympics Web Sites Win Gold Medals for Speed and Reliability; Mobile Web Sites Take Silver, Reports Keynote
BeaconEquity.com Issues Technical Trade Alerts on Healthcare Stocks: ZILA, VITA, EYE, JNJ, NVS, MRK
Ortho-McNeil Neurologics to Appeal Patent Ruling on RAZADYNE(R)
The CYPHER(R) Sirolimus-eluting Coronary Stent Outperforms the Taxus(R) Stent in People with Diabetes According to Clinical Data in the Journal of the American College of Cardiology
Advertisements
Home
|
Login
|
Research
|
Earnings
|
Scans
|
Chat Rooms
|
Charts
|
Submit Article
|
Join Blog Network
|
Contributors
|
copryright 2008 all rights reserved